Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-11-01
|
| Series: | Molecular & Cellular Oncology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/23723556.2019.1650631 |
| _version_ | 1827809316670799872 |
|---|---|
| author | Sachi Horibata |
| author_facet | Sachi Horibata |
| author_sort | Sachi Horibata |
| collection | DOAJ |
| description | We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies. |
| first_indexed | 2024-03-11T22:40:28Z |
| format | Article |
| id | doaj.art-10d293c5275c4c17909f4c07f355fffe |
| institution | Directory Open Access Journal |
| issn | 2372-3556 |
| language | English |
| last_indexed | 2024-03-11T22:40:28Z |
| publishDate | 2019-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Molecular & Cellular Oncology |
| spelling | doaj.art-10d293c5275c4c17909f4c07f355fffe2023-09-22T09:11:01ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562019-11-016610.1080/23723556.2019.16506311650631Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patientsSachi Horibata0National Cancer Institute, National Institutes of HealthWe recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.http://dx.doi.org/10.1080/23723556.2019.1650631leukemiaintrinsic resistancerna-sequencing |
| spellingShingle | Sachi Horibata Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients Molecular & Cellular Oncology leukemia intrinsic resistance rna-sequencing |
| title | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_full | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_fullStr | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_full_unstemmed | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_short | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_sort | transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| topic | leukemia intrinsic resistance rna-sequencing |
| url | http://dx.doi.org/10.1080/23723556.2019.1650631 |
| work_keys_str_mv | AT sachihoribata transcriptomicprofileofintrinsicallychemoresistantacutemyeloidleukemiapatients |